BioHarvest Sciences Inc.
BHST
$1.95
$0.042.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.21% | -31.93% | 13.77% | 30.86% | 25.67% |
| Total Depreciation and Amortization | 16.02% | 14.16% | 29.82% | 36.06% | 51.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.06% | 517.50% | -23.60% | -59.09% | -57.48% |
| Change in Net Operating Assets | -6,855.10% | -3,950.00% | -249.91% | -66.95% | -117.07% |
| Cash from Operations | -21.08% | -9.87% | -8.11% | -1.02% | -7.75% |
| Capital Expenditure | -2.71% | 31.33% | 16.93% | 23.38% | 18.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,840.54% | -439.36% | 94.79% | 98.38% | 116.44% |
| Cash from Investing | -51.77% | 5.94% | 21.87% | 28.14% | 25.71% |
| Total Debt Issued | -31.75% | 34.01% | 262.95% | 93.31% | 12.24% |
| Total Debt Repaid | -394.20% | -420.65% | -420.29% | -271.31% | -270.44% |
| Issuance of Common Stock | -- | 431.17% | 429.72% | 23.24% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 197.05% | 161.78% | 345.24% | 56.14% | -38.51% |
| Foreign Exchange rate Adjustments | 235.94% | 91.43% | 214.71% | -149.38% | -175.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 896.95% | 45,145.71% | 795.95% | 578.08% | -142.94% |